|
1
|
Hartgrink HH, Jansen EP, van Grieken NC
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Correa P: Gastric cancer: Overview.
Gastroenterol Clin North Am. 42:211–217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Patel TN, Roy S and Ravi R: Gastric cancer
and related epigenetic alterations. Ecancermedicalscience.
11:7142017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang L and Xu AM: SET and MYND domain
containing protein 3 in cancer. Am J Transl Res. 9:1–14.
2017.PubMed/NCBI
|
|
6
|
Greer EL and Shi Y: Histone methylation: A
dynamic mark in health, disease and inheritance. Nat Rev Genet.
13:343–357. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Albert M and Helin K: Histone
methyltransferases in cancer. Semin Cell Dev Biol. 21:209–220.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wood A and Shilatifard A:
Posttranslational modifications of histones by methylation. Adv
Protein Chem. 67:201–222. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin X, Huang Y, Zou Y, Chen X and Ma X:
Depletion of G9a gene induces cell apoptosis in human gastric
carcinoma. Oncol Rep. 35:3041–3049. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi XL, Guo ZJ, Wang XL, Liu XL and Shi
GF: SET8 expression is associated with overall survival in gastric
cancer. Genet Mol Res. 14:15609–15615. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu S, Chen D, Shen W, Chen L, Yu A, Fu H,
Sun K and Sun X: EZH2 mediates the regulation of S100A4 on
E-cadherin expression and the proliferation, migration of gastric
cancer cells. Hepatogastroenterology. 62:737–741. 2015.PubMed/NCBI
|
|
12
|
Guan X, Zhong X, Men W, Gong S, Zhang L
and Han Y: Analysis of EHMT1 expression and its correlations with
clinical significance in esophageal squamous cell cancer. Mol Clin
Oncol. 2:76–80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cebrian A, Pharoah PD, Ahmed S, Ropero S,
Fraga MF, Smith PL, Conroy D, Luben R, Perkins B, Easton DF, et al:
Genetic variants in epigenetic genes and breast cancer risk.
Carcinogenesis. 27:1661–1669. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peterson CL and Laniel MA: Histones and
histone modifications. Curr Biol. 14:R546–R551. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ordway JM and Curran T: Methylation
matters: Modeling a manageable genome. Cell Growth Differ.
13:149–162. 2002.PubMed/NCBI
|
|
17
|
Fritsch L, Robin P, Mathieu JR, Souidi M,
Hinaux H, Rougeulle C, Harel-Bellan A, Ameyar-Zazoua M and
Ait-Si-Ali S: A subset of the histone H3 lysine 9
methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a
multimeric complex. Mol Cell. 37:46–56. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiong Y, Li F, Babault N, Dong A, Zeng H,
Wu H, Chen X, Arrowsmith CH, Brown PJ, Liu J, et al: Discovery of
potent and selective inhibitors for G9a-Like protein (GLP) lysine
methyltransferase. J Med Chem. 60:1876–1891. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang J, Dorsey J, Chuikov S, Pérez-Burgos
L, Zhang X, Jenuwein T, Reinberg D and Berger SL: G9a and Glp
methylate lysine 373 in the tumor suppressor p53. J Biol Chem.
285:9636–9641. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Link PA, Gangisetty O, James SR,
Woloszynska-Read A, Tachibana M, Shinkai Y and Karpf AR: Distinct
roles for histone methyltransferases G9a and GLP in cancer
germ-line antigen gene regulation in human cancer cells and murine
embryonic stem cells. Mol Cancer Res. 7:851–862. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Simpson AJ, Caballero OL, Jungbluth A,
Chen YT and Old LJ: Cancer/testis antigens, gametogenesis and
cancer. Nat Rev Cancer. 5:615–625. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Biddle A and Mackenzie IC: Cancer stem
cells and EMT in carcinoma. Cancer metastasis Rev. 2012.(Epub Ahead
of Print). View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang L, Wu RL and Xu AM:
Epithelial-mesenchymal transition in gastric cancer. Am J Transl
Res. 7:2141–2158. 2015.PubMed/NCBI
|
|
25
|
Liu S, Ye D, Guo W, Yu W, He Y, Hu J, Wang
Y, Zhang L, Liao Y, Song H, et al: G9a is essential for
EMT-mediated metastasis and maintenance of cancer stem cell-like
characters in head and neck squamous cell carcinoma. Oncotarget.
6:6887–6901. 2015.PubMed/NCBI
|
|
26
|
Dong C, Wu Y, Yao J, Wang Y, Yu Y,
Rychahou PG, Evers BM and Zhou BP: G9a interacts with Snail and is
critical for Snail-mediated E-cadherin repression in human breast
cancer. J Clin Invest. 122:1469–1486. 2012. View Article : Google Scholar : PubMed/NCBI
|
